Aspirin's Benefit In Aggressive Breast Cancer
Aspirin May Show Benefit In Aggressive Breast Cancer A Christie NHS Foundation Trust research team in England has launched a new trial treating triple-negative breast-cancer patients with aspirin. They suspect aspirin could fight this aggressive form of breast cancer by making hard-to-treat tumours more responsive to anti-cancer drugs. It is aspirin's anti-inflammatory properties rather than its analgesic effect that could make it effective, the researchers said. In the trial, researchers said that some patients will be given aspirin as well as immunotherapy drug avelumab before they receive surgery and chemotherapy. If the study is successful it may lead to clinical trials of aspirin + avelumab for incurable secondary triple-negative breast cancer, which is when cancer cells that started in the breast metastasize to other parts of the body. The researchers said they hope the trial will show that, when combined with immunotherapy, aspirin can enhance its effects by preventing a weakening of the immune response to cancer drugs. This could lead to a new way to treat breast cancer. However, they also cautioned that it is too soon to recommend aspirin to breast cancer patients.
Source: https://www.instagram.com/p/ChrdfnEtneD/?igshid=YmMyMTA2M2Y=